~~<i id='53AD52AE79'><strike id='53AD52AE79'><tt id='53AD52AE79'><pre id='53AD52AE79'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：knowledge 2025-09-11 06:21:20 - browse：485

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Pancreatic cancer is often deadly, but new discoveries are raising hope

focus

leisure time

explore

Wikipedia

AlexHogan/STATThisisthefirstoftwostoriesonmonitoringthesafetyofnewdrugs —readthesecond here. Whenane

WSS

Covid silver lining: Unprecedented look at human immune system

Study: Black kids more likely to die after surgery than white kids

Alzheimer's risk factor APOE4 may be a distinct form of the disease

UnitedHealth quietly bought dozens of outpatient centers

The drug industry has found itself all alone in Washington

Oral obesity drug from Viking Therapeutics hits key early target

focus

explore

focus

New air purifier tech could be key to improving indoor air quality

Amylyx ALS drug fails large clinical trial

George Santos makes 1st court appearance after pleading not guilty to 13 counts

NEJM study link tiny plastics in blood vessels to heart problems

Duchenne breakthrough therapy leaves behind pioneering families

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Hollywood unions extend contract negotiations for actors

U.K. decision on ALS drug has neurologists, advocates up in arms

Apple is now the first public company to be valued at $3 trillion

Scientific mystery highlights the blind spots in genomics databases

focus

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Bird flu reported in person exposed to presumably infected cattle

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Medicare Advantage 2025 payments will dip, Biden administration says

Amylyx ALS drug failure raises questions and concerns

Pancreatic cancer is often deadly, but new discoveries are raising hope

leisure time

leisure time

explore

Wikipedia